Buyse, M., Sargent, D. J., Grothey, A., Matheson, A., & de Gramont, A. (2010). Biomarkers and surrogate end points—the challenge of statistical validation. Nature reviews. Clinical oncology, 7(6), 309-317. https://doi.org/10.1038/nrclinonc.2010.43
Chicago-Zitierstil (17. Ausg.)Buyse, Marc, Daniel J. Sargent, Axel Grothey, Alastair Matheson, und Aimery de Gramont. "Biomarkers and Surrogate End Points—the Challenge of Statistical Validation." Nature Reviews. Clinical Oncology 7, no. 6 (2010): 309-317. https://doi.org/10.1038/nrclinonc.2010.43.
MLA-Zitierstil (9. Ausg.)Buyse, Marc, et al. "Biomarkers and Surrogate End Points—the Challenge of Statistical Validation." Nature Reviews. Clinical Oncology, vol. 7, no. 6, 2010, pp. 309-317, https://doi.org/10.1038/nrclinonc.2010.43.